Exacerbation Rate Reduction According to Baseline Blood Eosinophilic Count in Patients with Asthma Treated with ICS/LABA Maintenance and Reliever Therapy

被引：0
|
作者：
Brusselle, G. G. [1 ]
Papi, A. [2 ]
Nicolini, G. [3 ]
Santoro, L. [3 ]
Guastalla, D. [3 ]
机构：
[1] Ghent Univ Hosp, Ghent, Belgium
[2] Univ Ferrara, Ctr Asma, Ferrara, Italy
[3] Chiesi, Parma, Italy
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1294
引用
收藏
页数：2
相关论文
共 33 条
  • [1] Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?
    Patel, Mitesh
    Pilcher, Janine
    Beasley, Richard
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (05) : 451 - 454
  • [2] Enabling Reductions in Maintenance ICS/LABA Therapy Using As Needed Anti-Inflammatory Reliever for Patients with Severe Eosinophilic Asthma Controlled with Benralizumab: SHAMAL Phase IV Clinical Study
    Jackson, Dj
    Kent, B. D.
    Humbert, M.
    Heaney, L. G.
    Korn, S.
    Keith, M.
    Siddiqui, S.
    Cook, B.
    Gil, E. G.
    Miller, de Giorgio A.
    PNEUMOLOGIE, 2021, 75 : S32 - S32
  • [3] Enabling Reductions in Maintenance ICS/LABA Therapy Using as Needed Anti-Inflammatory Reliever for Patients with Severe Eosinophilic Asthma Controlled with Benralizumab: SHAMAL Phase IV Clinical Study
    Jackson, D. J.
    Kent, B. D.
    Humbert, M.
    Heaney, L. G.
    Korn, S.
    Keith, M.
    Siddiqui, S.
    Cook, B.
    Garcia Gil, E.
    Miller, A. de Giorgio
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] Comparison of the Effects of Conventional Fixed ICS/LABA Combined Therapy Versus Combined Maintenance and Reliever ICS/Formoterol Therapy on the Treatment of Adherence and Inhaler Satisfaction of Asthma Patients Who Received Inhaler Education
    Gemicioglu, B.
    Sekibag, Y.
    Borekci, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Beclometasone dipropionate/formoterol maintenance and reliever therapy asthma exacerbation benefit increases with blood eosinophil level
    Brusselle, Guy
    Nicolini, Gabriele
    Santoro, Luigi
    Guastalla, Daniele
    Papi, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (01)
  • [6] Effect Of Mepolizumab On Health Status, Lung Function And Asthma Control According To Baseline Blood Eosinophil Count In Patients With Severe Eosinophilic Asthma
    Trevor, J. L.
    Albers, F. C.
    Nelsen, L. M.
    Bratton, D. J.
    Wang-Jairaj, J.
    Bradford, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [7] CAPTAIN: EFFECTS OF BASELINE SABA USE ON RESPONSE TO TRIPLE THERAPY IN PATIENTS WITH INADEQUATELY CONTROLLED ASTHMA ON ICS/LABA
    Busse, William
    Abbott, Carl
    Chang, Sarah
    Casale, Thomas
    Zarankaite, Agne
    Caceres, Diego Maselli
    CHEST, 2021, 160 (04) : 2357A - 2358A
  • [8] Predictive factors for asthma control according to ACQ5 in asthma patients treated with budesonide/formoterol maintenance and reliever therapy. Results from the EuroSMART study
    Aubier, M.
    Buhl, R.
    Haughney, J.
    Ostinelli, J.
    Ekstrom, T.
    Jorgensen, L.
    van Schayck, O. C. P.
    O'Connor, T.
    Faul, J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S474 - S474
  • [9] Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate-Severe Asthma: A Clinical Modelling and Simulation Study
    Paggiaro, Pierluigi
    Garcia, Gabriel
    Roche, Nicolas
    Verma, Manish
    Plank, Maximilian
    Oosterholt, Sean
    Duong, Janna K.
    Majumdar, Anurita
    Della Pasqua, Oscar
    ADVANCES IN THERAPY, 2024, 41 (11) : 4065 - 4088
  • [10] Patients Treated with Budesonide/Formoterol Maintenance and Reliever Therapy Achieve Asthma (GINA) Control and Reduced Risk of Exacerbations
    Bateman, E. D.
    Harrison, T. W.
    Quirce, S.
    Ostlund, O.
    Sears, M. R.
    Eriksson, G. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
1234